{name}
{subtitle}
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
city
~26 mi. (Santiago de Compostela, Spain, +383 more cities)
facility
Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia
biomarker
ER Negative, +2 more biomarkers
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +1 more type
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
city
~26 mi. (Santiago de Compostela, Spain, +147 more cities)
facility
Hosp Clin Univ de Santiago ( Site 0629)
condition
Cervical Adenocarcinoma, +2 more conditions
drug
brachytherapy, +3 more drugs
drug type
chemotherapy, +2 more types
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
city
~26 mi. (Santiago de Compostela, Spain, +93 more cities)
facility
CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 0660)
condition
Bladder Carcinoma, +1 more condition
drug
cisplatin, +4 more drugs
drug type
chemotherapy, +3 more types
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~26 mi. (Santiago de Compostela, Spain, +199 more cities)
facility
Complejo Hospitalario Universitario de Santiago ( Site 0668)
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
city
~26 mi. (Santiago de Compostela, Spain, +127 more cities)
facility
Complejo Hospitalario Universitario Santiago de Compostela
drug
cetuximab, +3 more drugs
drug type
chemotherapy, +1 more type
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~26 mi. (Santiago de Compostela, Spain, +260 more cities)
facility
Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia
biomarker
ERBB2 Amplification, +1 more biomarker
drug type
immunotherapy, +1 more type
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~26 mi. (Santiago de Compostela, Spain, +150 more cities)
facility
Hospital Clinico Universitario de Santiago ( Site 1207)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
city
~26 mi. (Santiago de Compostela, Spain, +81 more cities)
facility
Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia
drug
atezolizumab, +2 more drugs
drug type
immunotherapy, +1 more type
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
city
~26 mi. (Santiago de Compostela, Spain, +160 more cities)
facility
Hospital ClĂ­nico de Santiago
condition
Fallopian Tube Carcinoma, +2 more conditions
drug type
chemotherapy, +1 more type